Overview of Hepatitis B and
Hepatitis C Treatment
Hepatitis-B rates have declined by 82% since 1990. For the unfortunate 18%, however, we can discuss drug therapy for treatment of Hepatitis-B. Of the chronically infected people, 15% to 25% of these patients develop chronic liver disease. This includes things like cirrhosis, liver failure, or liver cancer. PharmCon freeCE offers MicroCE opportunities via our blog. […]